Market closedNon-fractional
BeyondSpring/BYSI
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX
About BeyondSpring
BeyondSpring Inc is engaged in clinical-stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. It has two reportable segments Plinabulin pipeline and the TPD platform.
Ticker
BYSI
Sector
Healthcare
Trading on
NASDAQ
Industry
Biotechnology
Headquarters
Florham Park, United States
Employees
36
Website
beyondspringpharma.com
BeyondSpring Metrics
BasicAdvanced
$81M
Market cap
-
P/E ratio
-$0.54
EPS
0.41
Beta
-
Dividend rate
Price and volume
Market cap
$81M
Beta
0.41
Financial strength
Current ratio
2.315
Quick ratio
1.006
Long term debt to equity
-14.339
Total debt to equity
-17.028
Management effectiveness
Return on assets (TTM)
-40.68%
Return on equity (TTM)
165.85%
Valuation
Price to revenue (TTM)
46.101
Price to book
-3.02
Price to tangible book (TTM)
-3.02
Price to free cash flow (TTM)
-4.87
Growth
Revenue change (TTM)
29.61%
Earnings per share change (TTM)
-36.66%
3-year revenue growth (CAGR)
113.47%
3-year earnings per share growth (CAGR)
-35.76%
What the Analysts think about BeyondSpring
Analyst Ratings
Majority rating from 1 analysts.
BeyondSpring Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q4 23
QoQ growth
Revenue
$1.7M
112.50%
Net income
-$21M
65.35%
Profit margin
-1,235.29%
-22.19%
BeyondSpring Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q1 21
Q2 21
Q3 21
Q4 21
Q1 22
Actual
-$0.44
-$0.49
-$0.47
-$0.24
-
Expected
-$0.54
-$0.33
-$0.38
-
$0.48
Surprise
-18.52%
50.31%
25.33%
-
-
BeyondSpring News
AllArticlesVideos
BeyondSpring To Host Virtual R&D Day to Discuss New Plinabulin Development Strategy for Cancer and Updates for SEED Therapeutics
GlobeNewsWire·3 months ago
BeyondSpring Provides Business Update and Reports Year End 2023 Financial Results
GlobeNewsWire·3 months ago
BeyondSpring Files 2023 Annual Report on Form 20-F
GlobeNewsWire·3 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional
Upcoming events
No upcoming events
FAQs
What’s the current market cap for BeyondSpring stock?
BeyondSpring (BYSI) has a market cap of $81M as of July 27, 2024.
What is the P/E ratio for BeyondSpring stock?
The price to earnings (P/E) ratio for BeyondSpring (BYSI) stock is 0 as of July 27, 2024.
Does BeyondSpring stock pay dividends?
No, BeyondSpring (BYSI) stock does not pay dividends to its shareholders as of July 27, 2024.
When is the next BeyondSpring dividend payment date?
BeyondSpring (BYSI) stock does not pay dividends to its shareholders.
What is the beta indicator for BeyondSpring?
BeyondSpring (BYSI) has a beta rating of 0.41. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.
Buy or sell BeyondSpring stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.